Proteasome Inhibitors

All categories
DBCAT003056Therapeutic categoryL01XG

Compounds that inhibit the function or proteolytic action of the PROTEASOME. A DrugBank category of 5 drugs. 4 of them are approved.

ATC classification
Also known as
Inhibitor, Proteasome · Inhibitors, Proteasome · Proteasome Endopeptidase Complex Inhibitors · Proteasome Inhibitor
Drugs

What you can answer from here — as of February 08, 2017

5DrugsEach linked to its full drug card
Listed above
7Drug targetsEvery drug–target pair in the class, with bond type
Sign in
321Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
7Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Proteasome Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In